Latest Breaking News On - Axel lehrer - Page 1 : comparemela.com

SuVax™ and MarVax™ Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX Conference

/PRNewswire/ Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing.

Soligenix extends patent protection for its filovirus vaccine platform to the UK and South Africa

Soligenix announced it has received notice of intent to grant additional patents based on its patent application in the UK and South Africa.

Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa

FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection

/PRNewswire/ Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing.

Soligenix Announces Publication Demonstrating Complete Protection Against Filovirus Disease in Nonhuman Primate Models of Ebola and Marburg Viruses

Single-vial thermostabilized bivalent vaccine demonstrates simultaneous protection against two lethal viruses PRINCETON, N.J., Jan. 2, 2024 /PRNewswire/ Soligenix, Inc. , a late-stage.